# Cellular, Molecular and Clinical Determinants of Bone Strength in in Vivo and Human Models of GH Excess.

> **NCT06344650** · — · RECRUITING · sponsor: **IRCCS San Raffaele** · enrollment: 100 (estimated)

## Conditions studied

- Acromegaly

## Interventions

- **PROCEDURE:** Blood sample
- **DIAGNOSTIC_TEST:** Radiological tests
- **OTHER:** Questionnaires

## Key facts

- **NCT ID:** NCT06344650
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-30
- **Primary completion:** 2024-10-31
- **Final completion:** 2026-04
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-08-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06344650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06344650, "Cellular, Molecular and Clinical Determinants of Bone Strength in in Vivo and Human Models of GH Excess.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06344650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*